News
Immune checkpoint inhibitors (ICIs), a powerful form of immunotherapy, have revolutionized cancer treatment by unleashing the ...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 30, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global ...
Learn how antibody-drug conjugates are advancing therapies for non-cancer conditions, unlocking new possibilities in ...
12d
News-Medical.Net on MSNNew monoclonal antibody enhances immune response by selectively targeting TregsA new research paper was published in Volume 16 of Oncotarget on July 9, 2025, titled "A novel anti-human CD25 mAb with ...
The most significant recent advances in the application of monoclonal antibodies (mAbs) to oncology have been the introduction and approval of bevacizumab (Avastin), an anti–vascular endothelial ...
Review Article Published: February 2007 Immunostimulatory monoclonal antibodies for cancer therapy Ignacio Melero, Sandra Hervas-Stubbs, Martin Glennie, Drew M. Pardoll & Lieping Chen Nature ...
Immunomodulatory therapeutic monoclonal antibodies that bind immune cells exhibit higher anti-tumor activity when they have a looser grip on immune cell receptors.
Anti-EGFR monoclonal antibodies (MAb) combined with chemotherapy in metastatic colon cancer (mCRC) patients (pts): Meta-analysis of randomized trials. Authors: Nirit Yarom, Avishay Sella, and Gillian ...
Session ID: 2025-07-23:d98251a6f35659ab35b8c63e Player Element ID: vjs_video_3 ...
A new pilot clinical study will explore the safety and effectiveness of 2 anti-canine monoclonal antibodies on solid tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results